首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The role of the invariant glutamate 95 in the catalytic site of Complex I from Escherichia coli
Authors:Liliya Euro
Institution:Helsinki Bioenergetics Group, Institute of Biotechnology, PO Box 65 (Viikinkaari 1) 00014 University of Helsinki, Finland
Abstract:Replacement of glutamate 95 for glutamine in the NADH- and FMN-binding NuoF subunit of E. coli Complex I decreased NADH oxidation activity 2.5-4.8 times depending on the used electron acceptor. The apparent Km for NADH was 5.2 and 10.4 μM for the mutant and wild type, respectively. Analysis of the inhibitory effect of NAD+ on activity showed that the E95Q mutation caused a 2.4-fold decrease of KiNAD+ in comparison to the wild type enzyme. ADP-ribose, which differs from NAD+ by the absence of the positively charged nicotinamide moiety, is also a competitive inhibitor of NADH binding. The mutation caused a 7.5-fold decrease of KiADP-ribose relative to wild type enzyme. Based on these findings we propose that the negative charge of Glu95 accelerates turnover of Complex I by electrostatic interaction with the negatively charged phosphate groups of the substrate nucleotide during operation, which facilitates release of the product NAD+. The E95Q mutation was also found to cause a positive shift of the midpoint redox potential of the FMN, from − 350 mV to − 310 mV, which suggests that the negative charge of Glu95 is also involved in decreasing the midpoint potential of the primary electron acceptor of Complex I.
Keywords:DDM  d-maltopyranoside" target="_blank">n-dodecyl β-d-maltopyranoside  HAR  hexaammineruthenium (III) chloride  DQ  decylubiquinone  dNADH  nicotinamide hypoxanthine dinucleotide reduced sodium salt  ADP-ribose  adenosine 5&prime  -diphosphoribose sodium salt  PMSF  phenylmethanesulfonyl fluoride  FeCy  ferricyanide
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号